257 related articles for article (PubMed ID: 20586944)
21. Exploring secular trends in the likelihood of receiving treatment for end-stage renal disease.
Hsu CY; Go AS; McCulloch CE; Darbinian J; Iribarren C
Clin J Am Soc Nephrol; 2007 Jan; 2(1):81-8. PubMed ID: 17699391
[TBL] [Abstract][Full Text] [Related]
22. [Epidemiology of chronic kidney disease].
Noël D; Landais P
Rev Prat; 2012 Jan; 62(1):38-42. PubMed ID: 22335065
[TBL] [Abstract][Full Text] [Related]
23. Increased risk of mortality in the elderly population with late-stage chronic kidney disease: a cohort study in Taiwan.
Hwang SJ; Lin MY; Chen HC; Hwang SC; Yang WC; Hsu CC; Chiu HC; Mau LW
Nephrol Dial Transplant; 2008 Oct; 23(10):3192-8. PubMed ID: 18450830
[TBL] [Abstract][Full Text] [Related]
24. Worsening renal failure in older chronic kidney disease patients with renal artery stenosis concurrently on renin angiotensin aldosterone system blockade: a prospective 50-month Mayo-Health-System clinic analysis.
Onuigbo MA; Onuigbo NT
QJM; 2008 Jul; 101(7):519-27. PubMed ID: 18375475
[TBL] [Abstract][Full Text] [Related]
25. Relationship between dyslipidemia and the risk of developing end-stage renal disease in a screened cohort.
Iseki K; Tozawa M; Ikemiya Y; Kinjo K; Iseki C; Takishita S
Clin Exp Nephrol; 2005 Mar; 9(1):46-52. PubMed ID: 15830273
[TBL] [Abstract][Full Text] [Related]
26. [Integrated care and expected outcomes over the progression of CKD (chronic kidney disease)].
Kimura G
Nihon Rinsho; 2008 Sep; 66(9):1807-13. PubMed ID: 18788414
[TBL] [Abstract][Full Text] [Related]
27. Slower decline of glomerular filtration rate in the Japanese general population: a longitudinal 10-year follow-up study.
Imai E; Horio M; Yamagata K; Iseki K; Hara S; Ura N; Kiyohara Y; Makino H; Hishida A; Matsuo S
Hypertens Res; 2008 Mar; 31(3):433-41. PubMed ID: 18497462
[TBL] [Abstract][Full Text] [Related]
28. Treatment of hypertension in chronic kidney disease.
Toto RD
Semin Nephrol; 2005 Nov; 25(6):435-9. PubMed ID: 16298269
[TBL] [Abstract][Full Text] [Related]
29. Metabolic syndrome and chronic kidney disease: a Japanese perspective on a worldwide problem.
Iseki K
J Nephrol; 2008; 21(3):305-12. PubMed ID: 18587718
[TBL] [Abstract][Full Text] [Related]
30. ESRD in Australia and New Zealand at the end of the millennium: a report from the ANZDATA registry.
McDonald SP; Russ GR; Kerr PG; Collins JF;
Am J Kidney Dis; 2002 Dec; 40(6):1122-31. PubMed ID: 12460029
[TBL] [Abstract][Full Text] [Related]
31. SCreening for Occult REnal Disease (SCORED): a simple prediction model for chronic kidney disease.
Bang H; Vupputuri S; Shoham DA; Klemmer PJ; Falk RJ; Mazumdar M; Gipson D; Colindres RE; Kshirsagar AV
Arch Intern Med; 2007 Feb; 167(4):374-81. PubMed ID: 17325299
[TBL] [Abstract][Full Text] [Related]
32. Different regional dynamics of end-stage renal disease in Japan by different causes.
Kato N; Usami T; Fukuda M; Motokawa M; Kamiya Y; Yoshida A; Kimura G
Nephrology (Carlton); 2005 Aug; 10(4):400-4. PubMed ID: 16109089
[TBL] [Abstract][Full Text] [Related]
33. Integrated therapies including erythropoietin decrease the incidence of dialysis: lessons from mapping the incidence of end-stage renal disease in Japan.
Furumatsu Y; Nagasawa Y; Hamano T; Iwatani H; Iio K; Shoji T; Ito T; Tsubakihara Y; Imai E
Nephrol Dial Transplant; 2008 Mar; 23(3):984-90. PubMed ID: 17956890
[TBL] [Abstract][Full Text] [Related]
34. Challenging chronic kidney disease: experience from chronic kidney disease prevention programs in Shanghai, Japan, Taiwan and Australia.
Chen N; Hsu CC; Yamagata K; Langham R
Nephrology (Carlton); 2010 Jun; 15 Suppl 2():31-6. PubMed ID: 20586945
[TBL] [Abstract][Full Text] [Related]
35. [Survey of risk factors and renal disease in first-degree relatives of dialysis patients].
Inserra F; de la Llave G; Alpino M; Castagna R; de la Fuente I; Dorado E; Norbis M; Pinelli L; Puddu M; Santos JC; Vivas N; Marelli C
Medicina (B Aires); 2007; 67(1):8-18. PubMed ID: 17408015
[TBL] [Abstract][Full Text] [Related]
36. [Epidemiology of chronic renal failure in the elderly].
Cobat A; Landais P
Rev Prat; 2005 Dec; 55(20):2230-6. PubMed ID: 16519049
[TBL] [Abstract][Full Text] [Related]
37. Epidemiology, impact and preventive care of chronic kidney disease in Taiwan.
Hwang SJ; Tsai JC; Chen HC
Nephrology (Carlton); 2010 Jun; 15 Suppl 2():3-9. PubMed ID: 20586940
[TBL] [Abstract][Full Text] [Related]
38. The epidemic of chronic kidney disease: looking at ageing and cardiovascular disease through kidney-shaped lenses.
Mangione F; Dal Canton A
J Intern Med; 2010 Nov; 268(5):449-55. PubMed ID: 20964736
[TBL] [Abstract][Full Text] [Related]
39. Reappraisal of proteinuria and estimated GFR to predict progression to ESRD or death for hospitalized chronic kidney disease patients.
Ohashi Y; Sakai K; Tanaka Y; Mizuiri S; Aikawa A
Ren Fail; 2011; 33(1):31-9. PubMed ID: 21219203
[TBL] [Abstract][Full Text] [Related]
40. Implementing KDOQI CKD definition and staging guidelines in Southern California Kaiser Permanente.
Rutkowski M; Mann W; Derose S; Selevan D; Pascual N; Diesto J; Crooks P
Am J Kidney Dis; 2009 Mar; 53(3 Suppl 3):S86-99. PubMed ID: 19231766
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
